SQZ Bio (SQZ) Stock Forecast, Price Target & Predictions
SQZ Stock Forecast
SQZ Bio stock forecast is as follows: an average price target of $400.00 (represents a 786836.85% upside from SQZ’s last price of $0.05) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
SQZ Price Target
SQZ Analyst Ratings
SQZ Bio Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 01, 2022 | - | Chardan Capital | $400.00 | $182.02 | 119.76% | 786836.85% |
SQZ Bio Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.05 | $0.05 | $0.05 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 01, 2022 | Chardan Capital | Buy | Buy | Hold |
SQZ Bio Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
SQZ | SQZ Bio | $0.44 | $400.00 | 90809.09% | Buy |
PMVP | PMV Pharmaceuticals | $1.64 | $24.75 | 1409.15% | Buy |
PCSA | Processa Pharmaceuticals | $1.11 | $9.00 | 710.81% | Buy |
ANTX | AN2 Therapeutics | $1.08 | $8.75 | 710.19% | Buy |
LIPO | Lipella Pharmaceuticals | $0.34 | $2.00 | 488.24% | - |
HOWL | Werewolf Therapeutics | $2.26 | $12.00 | 430.97% | Buy |
FENC | Fennec Pharmaceuticals | $4.65 | $15.75 | 238.71% | Buy |
ANEB | Anebulo Pharmaceuticals | $1.89 | $6.00 | 217.46% | Buy |
NUVB | Nuvation Bio | $2.29 | $6.75 | 194.76% | Buy |
KZR | Kezar Life Sciences | $7.09 | $17.50 | 146.83% | Buy |
IKT | Inhibikase Therapeutics | $2.61 | $5.00 | 91.57% | Buy |
SABS | SAB Biotherapeutics | $4.04 | $5.67 | 40.35% | Buy |
THRD | Third Harmonic Bio | $12.11 | $16.15 | 33.36% | Buy |
SQZ Forecast FAQ
Is SQZ Bio a good buy?
Yes, according to 1 Wall Street analysts, SQZ Bio (SQZ) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of SQZ's total ratings.
What is SQZ's price target?
SQZ Bio (SQZ) average price target is $400 with a range of $400 to $400, implying a 786836.85% from its last price of $0.0508. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will SQZ Bio stock go up soon?
According to Wall Street analysts' prediction for SQZ stock, the company can go up by 786836.85% (from the last price of $0.0508 to the average price target of $400), up by 786836.85% based on the highest stock price target, and up by 786836.85% based on the lowest stock price target.
Can SQZ Bio stock reach $0?
SQZ's average twelve months analyst stock price target of $400 supports the claim that SQZ Bio can reach $0 in the near future.